BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer
Condition(s):Thyroid CancerLast Updated:December 6, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Thyroid CancerLast Updated:December 6, 2017Completed
Condition(s):Papillary Thyroid CancerLast Updated:March 6, 2023Recruiting
Condition(s):Papillary Thyroid CancerLast Updated:January 13, 2012Completed
Condition(s):Positron-Emission Tomography; Lymph Node Metastases; Thyroid CancerLast Updated:July 28, 2022Recruiting
Condition(s):Galactin 3-thyroid CarcinomaLast Updated:January 27, 2023Not yet recruiting
Condition(s):Papillary Thyroid Cancer; Papillary Thyroid Carcinoma; Papillary Microcarcinoma of the ThyroidLast Updated:February 8, 2021Recruiting
Condition(s):Papillary Thyroid Carcinoma; Thermal AblationLast Updated:January 30, 2024Recruiting
Condition(s):Papillary Thyroid CancerLast Updated:June 12, 2017Completed
Condition(s):Patients With Papillary Thyroid Cancer and N1b StatusLast Updated:April 7, 2023Completed
Condition(s):Thyroid Cancer; RecurrenceLast Updated:October 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.